![BioCeros](https://parsers.vc/logo/2e6edfaf-e8e1-407c-912d-70204c1483e7-0.png)
Bioceros offers cell line generation services related to the preclinical development of monoclonal antibodies and generation of GMP-ready protein producing cell lines. BGV sold its stake in a management buyout in 2011.
Member count: 11-50
Investors 1
Date | Name | Website |
03.08.2021 | BioGenerat... | biogenerat... |